Steven Cohen's ANIP Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 399,092 shares of ANI Pharmaceuticals, Inc. (ANIP) worth $36.56 M, representing 0.06% of the portfolio. First purchased in 2023-Q1, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in ANIP, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 398,316 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's ANI Pharmaceuticals (ANIP) Holding Value Over Time
Track share changes against reported price movement
Quarterly ANI Pharmaceuticals (ANIP) Trades by Steven Cohen
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2023 | +485 | New Buy | 485 | $39.72 |
| Q2 2023 | +291 | Add 60.00% | 776 | $53.83 |
| Q3 2023 | -776 | Sold Out | 776 | $0.00 |
| Q3 2025 | +399,092 | New Buy | 399,092 | $91.60 |
Steven Cohen's ANI Pharmaceuticals Investment FAQs
Steven Cohen first purchased ANI Pharmaceuticals, Inc. (ANIP) in Q1 2023, acquiring 485 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held ANI Pharmaceuticals, Inc. (ANIP) for 11 quarters since Q1 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's largest addition to ANI Pharmaceuticals, Inc. (ANIP) was in Q3 2025, adding 399,092 shares worth $36.56 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 399,092 shares of ANI Pharmaceuticals, Inc. (ANIP), valued at approximately $36.56 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, ANI Pharmaceuticals, Inc. (ANIP) represents approximately 0.06% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's peak holding in ANI Pharmaceuticals, Inc. (ANIP) was 399,092 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.